The effects of female sex steroids on central serotonergic neurotransmission

Autor: Shanks, Elaine Anne

Acutely ovariectomised adult female Wistar rats were used to study the ability of oestrogen and progesterone to alter central 5-HT neurotransmission, with particular interest in changes in 5-HT2A receptor and serotonin transporter (SERT) binding site

Externí odkaz: http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.661779

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Attenuation of the effects of fluoxetine on serotonergic neuronal activity by pindolol in rats

Autor: Rasmussen, Kurt rasmussen_kurt@lilly.com, McCreary, Andrew C., Shanks, Elaine A.¹

Publikováno v: Neuroscience Letters. Jan2004, Vol. 355 Issue 1/2, p1. 4p.

The Dopamine D1 Receptor Positive Allosteric Modulator Mevidalen (LY3154207) Enhances Wakefulness in the Humanized D1 Mouse and in Sleep-Deprived Healthy Male Volunteers.

Autor: McCarthy AP; Eli Lilly and Company, Indianapolis, Indiana (K.A.S., W.K., K.M.B.) and Eli Lilly and Company, Surrey, United Kingdom (A.P.M., E.S., C.B., B.J.E., K.A.W.) mccarthy_andrew_peter@lilly.com., Svensson KA; Eli Lilly and Company, Indianapolis, Indiana (K.A.S., W.K., K.M.B.) and Eli Lilly and Company, Surrey, United Kingdom (A.P.M., E.S., C.B., B.J.E., K.A.W.)., Shanks E; Eli Lilly and Company, Indianapolis, Indiana (K.A.S., W.K., K.M.B.) and Eli Lilly and Company, Surrey, United Kingdom (A.P.M., E.S., C.B., B.J.E., K.A.W.)., Brittain C; Eli Lilly and Company, Indianapolis, Indiana (K.A.S., W.K., K.M.B.) and Eli Lilly and Company, Surrey, United Kingdom (A.P.M., E.S., C.B., B.J.E., K.A.W.)., Eastwood BJ; Eli Lilly and Company, Indianapolis, Indiana (K.A.S., W.K., K.M.B.) and Eli Lilly and Company, Surrey, United Kingdom (A.P.M., E.S., C.B., B.J.E., K.A.W.)., Kielbasa W; Eli Lilly and Company, Indianapolis, Indiana (K.A.S., W.K., K.M.B.) and Eli Lilly and Company, Surrey, United Kingdom (A.P.M., E.S., C.B., B.J.E., K.A.W.)., Biglan KM; Eli Lilly and Company, Indianapolis, Indiana (K.A.S., W.K., K.M.B.) and Eli Lilly and Company, Surrey, United Kingdom (A.P.M., E.S., C.B., B.J.E., K.A.W.)., Wafford KA; Eli Lilly and Company, Indianapolis, Indiana (K.A.S., W.K., K.M.B.) and Eli Lilly and Company, Surrey, United Kingdom (A.P.M., E.S., C.B., B.J.E., K.A.W.).

Publikováno v: The Journal of pharmacology and experimental therapeutics [J Pharmacol Exp Ther] 2022 Mar; Vol. 380 (3), pp. 143-152. Date of Electronic Publication: 2021 Dec 10.